Grožio injekcija - Company finances
|
EUR
|
2020
From: 2020-02-24
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 300 | - | - | - | 5,912 | 9,966 |
| Profit before tax | 215 | -707 | -696 | -766 | 502 | 1,064 |
| Net profit | 215 | -707 | -696 | -766 | 477 | 1,000 |
| Equity | 215 | -491 | -1,186 | -1,952 | -1,476 | -475 |
| Liabilities | 85 | 488 | 1,185 | 1,952 | 2,565 | 2,999 |
| Non-current assets | 0 | 0 | 0 | 0 | 364 | 267 |
| Current assets | 300 | -3 | -1 | 0 | 725 | 2,257 |
| Total assets | 300 | -3 | -1 | 0 | 1,089 | 2,524 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | - | - | 25 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | - | - | - | +68.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 71.7% | - | - | - | 43.8% | 39.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 71.7% | - | - | - | 8.1% | 10.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 71.7% | - | - | - | 8.5% | 10.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Grožio injekcija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-06 | 2026-05-31 | 1262.25 |
| 2025-12-02 | 2025-12-31 | 13.82 |
| 2024-05-15 | 2024-06-30 | 423.97 |
| 2024-05-06 | 2024-05-14 | 70.37 |
| 2024-05-02 | 2024-05-05 | 129.00 |
| 2024-04-11 | 2024-05-01 | 64.50 |
| 2024-04-03 | 2024-04-10 | 652.70 |
| 2024-03-01 | 2024-04-02 | 588.20 |
| 2024-02-01 | 2024-02-29 | 523.70 |
| 2024-01-03 | 2024-01-31 | 459.20 |
| 2023-12-01 | 2024-01-02 | 400.57 |
| 2023-11-03 | 2023-11-30 | 341.94 |
| 2023-10-03 | 2023-11-02 | 283.31 |
| 2023-09-18 | 2023-10-02 | 224.68 |
| 2023-09-01 | 2023-09-17 | 234.52 |
| 2023-08-01 | 2023-08-31 | 175.89 |
| 2023-07-03 | 2023-07-31 | 117.26 |
| 2023-05-02 | 2023-07-02 | 58.63 |
| 2023-04-11 | 2023-04-30 | 58.63 |
| 2023-04-03 | 2023-04-10 | 88.29 |
| 2023-03-31 | 2023-04-02 | 29.66 |
| 2023-02-21 | 2023-03-30 | 58.63 |
| 2023-02-01 | 2023-02-20 | 160.53 |
| 2023-01-03 | 2023-01-31 | 101.90 |
| 2022-12-01 | 2023-01-02 | 50.95 |
| 2022-11-11 | 2022-11-30 | 48.60 |
| 2022-11-03 | 2022-11-10 | 50.95 |
| 2022-10-25 | 2022-11-02 | 49.37 |
| 2022-10-24 | 2022-10-24 | 50.95 |
| 2022-10-03 | 2022-10-23 | 101.90 |
| 2022-09-05 | 2022-10-02 | 50.95 |
| 2022-09-01 | 2022-09-04 | 111.75 |
| 2022-08-31 | 2022-08-31 | 60.80 |
| 2022-08-02 | 2022-08-30 | 101.90 |
| 2022-06-07 | 2022-08-01 | 50.95 |
| 2022-06-01 | 2022-06-06 | 106.52 |
| 2022-05-03 | 2022-05-31 | 55.57 |
| 2022-04-08 | 2022-05-02 | 4.62 |
| 2022-04-01 | 2022-04-07 | 50.95 |
| 2022-03-08 | 2022-03-31 | 10.39 |
| 2022-03-07 | 2022-03-07 | 50.95 |
| 2022-03-01 | 2022-03-06 | 56.11 |
| 2022-02-09 | 2022-02-28 | 5.16 |
| 2022-02-01 | 2022-02-08 | 50.95 |
| 2022-01-03 | 2022-01-31 | 134.43 |
| 2021-12-01 | 2021-12-31 | 89.62 |
| 2021-11-04 | 2021-11-30 | 44.81 |
| 2021-10-01 | 2021-10-31 | 44.81 |
| 2021-09-01 | 2021-09-30 | 89.62 |
Grožio injekcija - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Grožio injekcija, MB (code 305480061) is a Small partnership engaged in retail sale of cosmetic and toilet articles. In the latest financial year, 2025, the company generated revenue of EUR 10.0K, up 68.6% year on year from EUR 5.9K in 2024. Net profit increased to EUR 1.0K in 2025 from EUR 477 in 2024, following a net loss of EUR 766 in 2023. Profitability remained positive and improved slightly, with a net profit margin of 10.0% in 2025 versus 8.1% in 2024. The balance sheet also strengthened during the year: total assets rose to EUR 2.5K from EUR 1.1K, driven mainly by short-term assets of EUR 2.3K, while long-term assets were EUR 267. Equity remained negative but improved to EUR -475 from EUR -1.5K, and liabilities increased to EUR 3.0K from EUR 2.6K. Return on assets was 39.6% in 2025, reflecting higher earnings relative to the asset base, while the negative equity position limits the usefulness of return on equity and leverage ratios.